Large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases
Basic Information
| Network | JPND | ||||||||
| Website | https://neurodegenerationresearch.eu/initiatives/annual-calls-for-proposals/2023-research-call-on-large-scale-analysis-of-omics-data-for-drug-target-finding-in-neurodegenerative-diseases/ | ||||||||
| Aim of the joint call | Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Worldwide, there are estimated to be 50 million people with Alzheimer’s disease and related disorders. This figure is expected to double every 20 years as the population ages. The total direct and informal care costs of Alzheimer’s, Parkinson’s and related disorders are expected to surpass €350 billion per year across the European Union. Existing treatments for neurodegenerative diseases are limited and mainly address the symptoms rather than the cause or the progressive course. With this in mind, JPND has identified a pressing need for investment aimed at enabling research projects on large scale analysis of Omics data for drug-target finding in neurodegenerative diseases. | ||||||||
| Type of joint call | Two Stages - Call with pre-proposals and full proposals submissions | ||||||||
| Events |
|
||||||||
| Is call co-funded? | No | ||||||||
| Call follow up funding | n/a | ||||||||
| Call reasons | n/a | ||||||||
| Research fields |
|
||||||||
| Type of research | n/a | ||||||||
| Target groups | n/a | ||||||||
| Participating networks | n/a |